Detalles de la búsqueda
1.
Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting.
Cancer Biol Med
; 19(8)2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36069539
2.
Comparison of efficacy and safety of obinutuzumab-based regimen versus rituximab-based regimen in treatment of B-cell non-Hodgkin lymphoma: a Meta-analysis / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 610-617, 2022.
Artículo
en Zh
| WPRIM | ID: wpr-954008
3.
Effect of excessive activation of PI3K signaling pathway on the prognosis of patients with non-Hodgkin lymphoma and the efficacy of targeted drugs / 国际肿瘤学杂志
Journal of International Oncology
; (12): 121-124, 2021.
Artículo
en Zh
| WPRIM | ID: wpr-882520
4.
Prognostic value of D-dimer level in patients with newly diagnosed diffuse large B-cell lymphoma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 151-155, 2021.
Artículo
en Zh
| WPRIM | ID: wpr-882255
5.
Progress of histone deacetylase inhibitors in treatment of non-Hodgkin lymphoma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 573-576, 2020.
Artículo
en Zh
| WPRIM | ID: wpr-862880
6.
Comparative analysis between HP-083/4 and rational used instrument on results of six items / 国际检验医学杂志
International Journal of Laboratory Medicine
; (12): 2789-2791,2793, 2015.
Artículo
en Zh
| WPRIM | ID: wpr-602485
Resultados
1 -
6
de 6
1
Próxima >
>>